Egret Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
250 Park Ave Fl 7, New York, New York, 1...Website
www.egrettherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Egret Therapeutics
Egret Therapeutics focuses on modulating innate immunity to preserve function following acute ischemic injury. The company develops innovative therapeutic solutions aimed at enhancing recovery and improving patient outcomes. Their products and services are intended for healthcare providers and researchers in the field of immunology and acute care. Egret Therapeutics is dedicated to advancing treatments that address critical health challenges related to ischemic conditions.Explore more
Popular SearchesEgret TherapeuticsSIC Code 28,283NAICS Code 32,325Show moreEgret Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Egret Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Egret Therapeutics is spiking on competitors!
Product Launch: Get notified when Egret Therapeutics launches new products
Check if Egret Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Egret Therapeutics
Click to see if Egret Therapeutics had a recent Job posting/layoffs
Egret Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Egret Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Egret Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Egret Therapeutics
Compare insights from companies similar to Egret Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Egret Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Egret Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Egret Therapeutics.
Egret Therapeutics Tech Stack
A closer look at the technologies used by Egret Therapeutics
Egret Therapeutics News & Media
Egret Therapeutics Appoints Dr. Geoffrey Ling to Scientific Advisory Board - Advancing its Mission to Address Critical Military Health Needs
Egret Therapeutics, a portfolio company of Turret Capital Management, is a clinical stage biotechnology company focused on function preservation following acute injuries NEW YORK, July 14, 2025 /PRNewswire/ -- Egret Therapeutics today announced the appointment of Dr. Geoffrey Ling, MD,...Egret Therapeutics Announces Appointment of Ron Cohen, M.D. to its Board of Directors
Egret Therapeutics, a portfolio company of Turret Capital Management, is a clinical stage biotechnology company focused on function preservation post acute ischemic injury NEW YORK, Sept. 4, 2024 /PRNewswire/ -- Egret Therapeutics today announced the appointment of Dr. Ron Cohen to its...Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia
Egret Therapeutics, a portfolio company of Turret Capital Management, announces FDA Clearance of its IND Application for EGT 101 NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for...Egret Therapeutics Announces the Addition of Three New Members to its Scientific Advisory Board
Egret Therapeutics, a portfolio company of Turret Capital Management, Announces the Addition of Three New Members. NEW YORK, Jan. 3, 2023 /PRNewswire/ -- Egret Therapeutics, a clinical-stage company focused on the treatment of neurological diseases, today announced the expansion of its...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Egret Therapeutics
Sign Up For FreeTo access detailed company insights
Egret Therapeutics focuses on modulating innate immunity to preserve function following acute ischemic injury. The company develops innovative therapeutic solutions aimed at enhancing recovery and improving patient outcomes. Their products and services are intended for healthcare providers and researchers in the field of immunology and acute care.... Read More
